Lung Cancer Patient Advocacy Progress and New Challenges Since 2006

Area of Science:

• Oncology
• Public Health
• Patient Advocacy

Background:

• Lung cancer patients historically lacked recognition and support compared to other cancer groups.
• Limited systemic therapy benefits in the 1990s hindered support networks and advocacy efforts.
• Recent decades saw major advances in lung cancer treatment, diagnostics, and screening, improving patient experience.

Purpose of the Study:

• To highlight the critical role of lung cancer patient advocacy in advancing care.
• To demonstrate how advocacy drives progress in prevention, screening, treatment, and supportive care.
• To underscore advocacy's impact on policy, public perception, and research collaboration.

Main Methods:

• Review of historical trends in lung cancer patient support and advocacy.
• Analysis of the impact of scientific advancements on patient experience.
• Examination of the evolution and strategies of lung cancer advocacy organizations.
• Case examples of European and African advocacy initiatives.

Main Results:

• Advocacy organizations have become essential partners, influencing research design, policy, and public perception.
• Social media and biomarker-driven communities have fostered patient connection and collaboration since the 2010s.
• Progress has been made in tobacco control and reducing stigma, though challenges remain.
• Global advocacy is developing, with initiatives like the Pan-African Lung Cancer Conference prioritizing key issues.

Conclusions:

• Patient advocacy is indispensable for promoting equitable access, innovation, and survivorship support in lung cancer care.
• Formal integration of advocates into research and clinical guideline development is crucial for sustained progress.
• The field is moving towards an 'Impact Era,' focusing on quality of life alongside survival.
• Continued advocacy efforts are vital to ensure patient-centered and equitable lung cancer care worldwide.